Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Hair color is not a risk factor for developing alopecia areata.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Atopic dermatitis increases the risk of some autoimmune diseases.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.